Literature DB >> 30057458

Quality of Life of Patients Under Anticoagulant Therapy Compared to Patients Treated with Antiplatelet Therapy.

Eda Çoban1, Dilek Ataklı1, Aysun Soysal1, Dursun Kırbaş2.   

Abstract

INTRODUCTION: Health-related quality of life (HRQoL) includes the physical, functional, social, and emotional well-being of an individual. The most important and frequently used generic HRQoL assessment is Short Form- 36 (SF-36). The objective of this study was to analyze the HRQoL of patients under chronic use of oral anticoagulants in a specialized stroke unit.
METHODS: One hundred and twenty-six stroke patients from our stroke clinic between April 1, 2014 and June 1, 2014 were included in this cross-sectional study. The inclusion criteria included only patients whose Rankin score was "0" and were on oral anticoagulant or antiplatelet treatment for ≥1 year. Questionnaire SF-36 was used for the study. The patients' age, sex, comorbidities, medical treatments, modified Rankin Scores, bleeding complications, emergency polyclinic admissions, and hospitalization were also noted.
RESULTS: Seventy-five of them were men. The median age was 55.67± 14.23 years. Seventy-seven of the patients were on anticoagulant therapy. Being on anticoagulation therapy did not influence the domains of HRQoL. All of the domains presented the lowest scores in female group. The domains of general health, physical function, and vitality had the lowest scores among hypertensive patients. The domains of physical function, role function, vitality, and mental health had significantly lower scores in the diabetic group. Bodily pain scores were lowest in patients having recurrent stroke attacks. Stroke patients taking more than 3 drugs were found to have worse QoL scores.
CONCLUSION: Patients under chronic treatment with oral anticoagulants had no negative perception of QoL when attending an anticoagulation specialized outpatient clinic.

Entities:  

Keywords:  Quality of life; anticoagulant therapy; antiplatelet therapy; stroke

Year:  2018        PMID: 30057458      PMCID: PMC6060649          DOI: 10.5152/npa.2016.159

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  11 in total

1.  Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study.

Authors:  P J Devereaux; D R Anderson; M J Gardner; W Putnam; G J Flowerdew; B F Brownell; S Nagpal; J L Cox
Journal:  BMJ       Date:  2001-11-24

2.  Patients' perceptions regarding oral anticoagulation therapy and its effect on quality of life.

Authors:  P Casais; S S Meschengieser; A Sanchez-Luceros; M A Lazzari
Journal:  Curr Med Res Opin       Date:  2005-07       Impact factor: 2.580

3.  Sex differences in health-related quality of life among adult stroke patients in Northeastern China.

Authors:  Xiaoning Wu; Lianqiu Min; Lin Cong; Yujie Jia; Chang Liu; Haiping Zhao; Ping Liu; Yumin Luo
Journal:  J Clin Neurosci       Date:  2013-11-09       Impact factor: 1.961

4.  The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.

Authors:  T R Lancaster; D E Singer; M A Sheehan; L B Oertel; S W Maraventano; R A Hughes; J P Kistler
Journal:  Arch Intern Med       Date:  1991-10

5.  Sex differences in management and outcome after stroke: a Swedish national perspective.

Authors:  Eva-Lotta Glader; Birgitta Stegmayr; Bo Norrving; Andreas Terént; Kerstin Hulter-Asberg; Per-Olov Wester; Kjell Asplund
Journal:  Stroke       Date:  2003-07-10       Impact factor: 7.914

Review 6.  Assessing patient wellness: new perspectives on quality of life and compliance.

Authors:  G H Williams
Journal:  Am J Hypertens       Date:  1998-11       Impact factor: 2.689

7.  Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry.

Authors:  Antonio Di Carlo; Maria Lamassa; Marzia Baldereschi; Giovanni Pracucci; Anna Maria Basile; Charles D A Wolfe; Maurice Giroud; Anthony Rudd; Augusto Ghetti; Domenico Inzitari
Journal:  Stroke       Date:  2003-04-10       Impact factor: 7.914

Review 8.  Antiplatelet therapy for atherothrombotic disease: an update for the primary care physician.

Authors:  George E Kikano; Marie T Brown
Journal:  Mayo Clin Proc       Date:  2007-05       Impact factor: 7.616

9.  Quality of life analysis of patients in chronic use of oral anticoagulant: an observational study.

Authors:  Geisa de Queiroz Almeida; Lúcia de A C B Noblat; Luiz Carlos Santana Passos; Harrison Floriano do Nascimento
Journal:  Health Qual Life Outcomes       Date:  2011-10-25       Impact factor: 3.186

10.  Sex differences in stroke recovery.

Authors:  Sue-Min Lai; Pamela W Duncan; Paul Dew; John Keighley
Journal:  Prev Chronic Dis       Date:  2005-06-15       Impact factor: 2.830

View more
  1 in total

1.  Statistical analysis for efficacy of tirofiban combined with ozagrel in the treatment of progressive cerebral infarction patients out of thrombolytic therapy time window.

Authors:  Huiying Zhang; Lei Zheng
Journal:  Clinics (Sao Paulo)       Date:  2021-06-14       Impact factor: 2.365

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.